TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe
- K. Szymańska
- , L. E. Moore
- , N. Rothman
- , W. H. Chow
- , F. Waldman
- , E. Jaeger
- , T. Waterboer
- , L. Foretova
- , M. Navratilova
- , V. Janout
- , H. Kollarova
- , D. Zaridze
- , V. Matveev
- , D. Mates
- , N. Szeszenia-Dabrowska
- , I. Holcatova
- , V. Bencko
- , F. Le Calvez-Kelm
- , S. Villar
- , M. Pawlita
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations